Asensus Surgical, Inc. (2TX.F)

0,2142 -0,0252 (-10,53%) Ab 09:24AM CEST. Markt geöffnet.

Asensus Surgical, Inc.

1 TW Alexander Drive
Suite 160
Durham, NC 27703
United States
919 765 8400
https://www.asensus.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 207

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Anthony Fernando	President, CEO & Director	747,09k	N/A	1972
Mr. Shameze Rampertab B.Sc. MBA, CA, CPA	Executive VP & CFO	441,29k	N/A	1967
Mr. Joshua B. Weingard	Chief Legal Officer & Secretary	N/A	N/A	1973
Mr. Ethan Loiselle	Vice President of Global Marketing	N/A	N/A	N/A
Ms. Amanda Owens	Vice President of People	N/A	N/A	N/A
Mr. Ravi Kommineni	Head of Global Quality & Regulatory	N/A	N/A	N/A
Mr. Motti Frimer	Vice President of R&D, Digital Solutions and MD of Asensus Surgical	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Corporate Governance

Asensus Surgical, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 10, Vorstand: 6, Shareholderrechte: 3, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.